Insurance coverage for pharmacogenomic testing in the USA

被引：10
作者：
Williams, Marc S. [1 ]
机构：
[1] Intermountain Healthcare, Clin Genet Inst, Salt Lake City, UT 84103 USA
来源：
PERSONALIZED MEDICINE | 2007年 / 4卷 / 04期
关键词：
clinical utility; clinical validity; coverage decision; experimental; investigational; medical necessity; oversight; pharmacogenetics; pharmacogenomics;
D O I：
10.2217/17410541.4.4.479
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The completion of the Human Genome Project has led to claims that we are on the verge of entering the era of 'personalized medicine'. Some initial, highly visible successes have positioned pharmacogenomics as the poster child for this new era. Many commercial referral laboratories are offering pharmacogenomic assays. In the US healthcare system, payers have had a significant impact on utilization of new drugs and technologies. Payers are frequently characterized as a barrier to the rapid dissemination of innovative therapies. In reality, payers are frequently the only group that scrutinize these new therapies for utility. As such, they play a critical role in assuring that their members are receiving appropriate care.
引用
收藏
页码：479 / 487
页数：9
相关论文
共 26 条
[1]  
ALEXANDER T, 1979, FORTUNE, V100, P126
[2]  
Anderson J. L., 2007, CIRCULATION
[3]  
ANSTEY A, 1992, J ROY SOC MED, V85, P752
[4]   Guidelines for prescribing azathioprine in dermatology [J].
Anstey, AV ;
Wakelin, S ;
Reynolds, NJ .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (06) :1123-1132
[5]   POLICY IMPLICATIONS OF THE DIFFUSION AND CONTROL OF MEDICAL TECHNOLOGY [J].
BANTA, HD ;
BURNS, AK ;
BEHNEY, CJ .
ANNALS OF THE AMERICAN ACADEMY OF POLITICAL AND SOCIAL SCIENCE, 1983, 468 (JUL) :165-181
[6]  
Brown E, 1993, Physician Exec, V19, P60
[7]   Guidelines for the management of inflammatory bowel disease in adults [J].
Carter, MJ ;
Lobo, AJ ;
Travis, SPL .
GUT, 2004, 53 :v1-v16
[8]  
CUPPENS H, 1995, EUR J HUM GENET, V3, P235
[9]   The risk for and severity of bleeding complications in elderly patients treated with warfarin [J].
Fihn, SD ;
Callahan, CM ;
Martin, DC ;
McDonell, MB ;
Henikoff, JG ;
White, RH .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) :970-+
[10]   The FDA and drug safety - A proposal for sweeping changes [J].
Furberg, Curt D. ;
Levin, Arthur A. ;
Gross, Peter A. ;
Shapiro, Robyn S. ;
Strom, Brian L. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (18) :1938-1942
123